Dr. David B. Konrad
Gruppenleiter
Department Pharmazie
Chemical Proteomics-guided Drug Development
Forschungsgebiete
- Drug Development
- Chemical Proteomics
- Non-Small Cell Lung Cancer
- Chemical Methodology Development
Kurzlebenslauf
- From 2021 Liebig Fellow, LMU Munich
- 2019-2020 LMU Research Fellow (Ivan Huc)
- 2018-2019 Postdoctoral Research, Scripps Research, La Jolla (Ben Cravatt)
- 2014-2018 Ph.D. Organic Chemistry, LMU Munich (Dirk Trauner)
- 2011-2013 M.Sc. Biochemistry, LMU Munich, University of California, Berkeley and Max-Planck-Institute, Mülheim a. d. Ruhr
- 2007–2011 B.Sc. Chemistry and Biochemistry, LMU Munich and University of Ottawa
Wichtige Publikationen
- “A concise synthesis of tetrodotoxin”
D. B. Konrad#, K.-P. Ruehmann#, H. Ando, B. Hetzler, N. Strassner, K. N. Houk, B. Matsuura#*, D. Trauner*,
Science 2022, 377, 411–415.
- “An activity-guided map of electrophile-cysteine interactions in primary human immune cells”
E. V. Vinogradova,* X. Zhang, D. Remillard, D. C. Lazar, R. M. Suciu, Y. Wang, G. Bianco, Y. Yamashita, V. M. Crowley, M. A. Schafroth, M. Yokoyama, D. B. Konrad, K. M. Lum, G. M. Simon, E. K. Kemper, M. R. Lazear, S. Yin, M. M. Blewett, M. M.Dix, N. Nguyen, M. N. Shokhirev, E. Chin, L. Lairson, B. Melillo, S. L. Schreiber, S. Forli, J. R. Teijaro,* B. F. Cravatt*, Cell 2020, 182, 1009–1026.
- “Computational Design and Synthesis of a Deeply Red-Shifted and Bistable Azobenzene”
D. B. Konrad#*, G. Savasci#, L. Allmendinger, D. Trauner, C. Ochsenfeld*, A. M. Ali*,
J. Am. Chem. Soc. 2020, 142, 6538–6547
- # equally contributing co-first authors; * co-corresponding authors.
- “Synthesis of Redshifted Azobenzene Photoswitches via Late-Stage Functionalization“
D. B. Konrad, J. A. Frank, D. Trauner*,
Chem. Eur. J. 2016, 22, 4364–4368.